Condition: Breast Cancer · Sponsor: American College of Radiology
The over-arching goal of the Contrast-Enhanced Spectral Mammography Imaging Screening Trial (CMIST) is to determine if dual-energy contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis (DBT) in women with dense breasts. Aim 1: To evaluate the performance of CESM compared to DBT at baseline for breast-cancer screening in women with dense breasts. Aim 2: To evaluate the performance of CESM compared to DBT at the 1-year follow up for breast-cancer screening in women with dense breasts.
This description comes directly from the study's public registry record.
Christopher Comstock, MD · 212-746-6000 · chc4050@med.cornell.edu
Etta Pisano, MD
Always discuss trial participation with your own doctor first.
| University of Alabama, Birmingham | Birmingham, Alabama, United States | Recruiting |
| Boca Raton Regional Hospital - Christine E. Lynn Women's Health and Wellness Institute | Boca Raton, Florida, United States | Recruiting |
| Lake Medical Imaging | The Villages, Florida, United States | Active Not Recruiting |
| Boston Breast Diagnostic Center | Wellesley Hills, Massachusetts, United States | Recruiting |
| Henry Ford Health | Detroit, Michigan, United States | Recruiting |
| Thomas Jefferson University | Sewell, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Carolina Breast Imaging Specialists | Greenville, North Carolina, United States | Recruiting |
| Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
| St. Joseph's Hospital | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05625659